Edition:
United Kingdom

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

8.87USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$8.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
54,753
52-wk High
$17.39
52-wk Low
$7.21

Chart for

About

AC Immune SA is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology... (more)

Overall

Beta: --
Market Cap(Mil.): $639.40
Shares Outstanding(Mil.): 56.77
Dividend: --
Yield (%): --

Financials

  ACIU.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -0.69 -- --
ROI: -32.55 1.70 14.60
ROE: -33.72 3.17 16.33

BRIEF-AC Immune Says Co's Selling Shareholder May Sell Up To 18 Mln Common Shares

* AC IMMUNE SAYS CO'S SELLING SHAREHOLDER MAY SELL UP TO 18 MILLION COMMON SHARES Source text: (https://bit.ly/2P0dXMm) Further company coverage:

24 Aug 2018

Earnings vs. Estimates